Human mesenchymal stromal cells improve scar thickness without enhancing cardiac function in a chronic ischaemic heart failure model

Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction

(2011) Victor Dayan et al.   BASIC RESEARCH IN CARDIOLOGY

Cardioprotective Effects of a Selective B2 Receptor Agonist of Bradykinin Post-Acute Myocardial Infarct

(2010) M. Marketou et al.   AMERICAN JOURNAL OF HYPERTENSION

Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy

(2009) K. H. Schuleri et al.   EUROPEAN HEART JOURNAL

A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction

(2009) Joshua M. Hare et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity

(2009) H. C. Quevedo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MESENCHYMAL STEM CELLS PROMOTE CARDIOMYOCYTE HYPERTROPHYIN VITROTHROUGH HYPOXIA-INDUCED PARACRINE MECHANISMS

(2008) Rui-Xia Xu et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Bone Marrow-Derived Mesenchymal Stromal Cells Express Cardiac-Specific Markers, Retain the Stromal Phenotype, and Do Not Become Functional Cardiomyocytes In Vitro

(2008) Robert A. Rose et al.   STEM CELLS